The 26th Congress of the European Hematology Association (EHA) 2021, 9-17 June, will see leading experts from around the globe gather virtually for a fantastic demonstration of the most ground-breaking research in the field of hematology.

Exciting data on promising biomarkers, CAR T-cell and NK-cell therapy, transplant research, novel drugs and more will be showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalessemia, and beyond.

View all videos

EHA 2021

The 26th Congress of the European Hematology Association (EHA) 2021
09–17 June 2021 | Virtual Meeting

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

EHA 2021

The 26th Congress of the European Hematology Association (EHA) 2021
09–17 June 2021 | Virtual Meeting

The 26th Congress of the European Hematology Association (EHA) 2021, 9-17 June, will see leading experts from around the globe gather virtually for a fantastic demonstration of the most ground-breaking research in the field of hematology.

Exciting data on promising biomarkers, CAR T-cell and NK-cell therapy, transplant research, novel drugs and more will be showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalessemia, and beyond.

View all videos

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter